SUMOylation and DeSUMOylation: Prospective therapeutic targets in cancer

Wenyan Wu1, Chao Huang1

  • 1Kunming University of Science and Technology, Medical School, Kunming 650500, China.

Life Sciences
|September 18, 2023
PubMed

Insights

The SUMOylation pathway, a protein modification system, impacts cellular processes and is implicated in tumor development. Understanding SUMOylation and its related therapeutic drugs is crucial for cancer research.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cell Biology

Background:

  • SUMOylation is a ubiquitin-like protein modification involving E1, E2, and E3 enzymes, distinct from ubiquitination's direct protein degradation.
  • The SUMO family comprises SUMO1-5 subtypes, with sentrin/SUMO-specific proteases (SENPs) regulating the reverse SUMOylation process.
  • SUMOylation influences protein localization, activation, and turnover, affecting numerous cellular reactions.

Purpose of the Study:

  • To review the components of the SUMOylation pathway.
  • To explore the interplay between SUMOylation and other post-translational modifications.
  • To discuss therapeutic strategies targeting the SUMOylation pathway in diseases, particularly cancer.

Main Methods:

  • Literature review of SUMOylation pathway members and functions.
  • Analysis of SUMOylation's interactions with other post-translational modifications.
  • Examination of therapeutic drug development related to SUMOylation.

Main Results:

  • SUMOylation pathway proteins are frequently abnormally expressed in tumors.
  • SUMOylation is closely linked to tumor occurrence, metastasis, and invasion.
  • The SUMOylation system plays a significant role in cellular regulation and disease pathology.

Conclusions:

  • The SUMOylation pathway is a critical regulator of cellular processes and a potential target for cancer therapy.
  • Further research into SUMOylation, its modifications, and therapeutic interventions is warranted.
  • Understanding the complex network of SUMOylation interactions can lead to novel treatment strategies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K